A critical appraisal of six modern classifications of ductal carcinoma in situ of the breast (DCIS): Correlation with grade of associated invasive carcinoma

Histopathology

Volumn 29, Issue 5, 1996, Pages 397-409

  Douglas Jones, A G ^a   Gupta, S K ^a   Attanoos, R L ^a   Morgan, J M ^a   Mansel, R E ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Breast; Classification; Duct carcinoma; Ductal carcinoma in situ (DCIS)

Indexed keywords

ARTICLE; BREAST CARCINOMA; CANCER CLASSIFICATION; CANCER GRADING; CARCINOMA IN SITU; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 0029852019     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.1996.d01-513.x     Document Type: Article

References (35)

1. Van Dongen JA, Holland R, Peterse JL et al. Ductal carcinoma in-situ of the Breast; Second EORTC Consensus Meeting. Eur. J. Cancer 1992; 28; 626-629.
2. Patchefsky AS, Schwartz GF, Finkelstein SD et al. Heterogeneity of intraductal carcinoma of the breast. Cancer 1989;63; 731-741.
3. Lennington WJ, Jensen RA, Dalton LW, Page DL. Ductal carcinoma in situ of the breast - Heterogeneity of individual lesions. Cancer 1994; 73; 118-124.
4. Lagios MD. Heterogeneity of ductal carcinoma in situ of the breast. J. Cell Biochem. 1993; (Suppl.) 17G; 49-52.
5. Bobrow LG, Happerfield LC, Gregory WM, Springall RD, Millis RR. The classification of ductal carcinoma in situ and its association with biological markers. Semin Diagn Pathol. 1994; 11; 199-207.
6. Lagios MD. Heterogenity of duct carcinoma in situ (DCIS): relationship of grade and subtype analysis to local recurrence and risk of invasive transformation. Cancer Lett. 1995; 90; 97-102.
7. Zafrani B, Leroyer A, Forquet A et al. Mammographically detected ductal in situ carcinoma of the breast analysed with a new classification, a study of 127 cases: Correlation with estrogen and progesterone receptors, p53 and c-erb B-2 proteins and proliferative activity. Semin Diag Pathol. 1994; 11; 208-214.
8. Leal CB, Schmitt FC, Bento MJ, Maia NC, Lopes CS. Ductal carcinoma in situ of the breast. Histologic categorization and its relationship to ploidy and immunohistochemical expression of hormone receptors, p53 and c-erb B-2 protein. Cancer 1995; 75; 2123-2131.
9. Bellamy CO, McDonald C, Salter DM, Chetty U, Anderson TJ, Noninvasive ductal carcinoma of the breast: the relevance of histologic categorization. Hum. Pathol. 1993; 24; 16-23.
10. National Coordinating Group for Breast Screening Pathology. Pathology Reporting in Breast Cancer Screening. 2nd ed. 1995; 23-27.
11. Silverstein MJ, Poller DN, Waisman JR et al. Prognostic classification of breast ductal carcinoma in situ. Lancet 1995; 345; 1154-1157.
12. Holland R, Peterse JL, Millis RR et al. Ductal carcinoma in situ: a proposal for a new classification. Semin. Diagn. Pathol. 1994; 11; 167-180.
13. Poller DN, Silverstein MJ, Galea M et al. Ductal carcinonia in situ of the breast: a proposal for a new simplified histological classification association between cellular proliferation and c- erbB-2 protein expression. Mod. Pathol. 1994; 7; 257-262.
14. Douglas-Jones AG, Schmid KW, Bier B, et.al. Metallothionein expression in duct carcinoma in situ of the breast. Human Pathol. 1995; 26; 217-222.
15. Todd JH, Dowle C, Williams MR, et.al. Confirmation of a prognostic index in primary breast cancer. Br. J. Cancer 1987; 56; 489-492.
16. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer 1. The value of histological grade in breast cancer: experience from a large study with long term follow up. Histopathology 1991; 19; 403-410.
17. National Coordinating Gronp for Breast Screening Pathology. Pathology Reporting in Breast Cancer Screening. 2nd ed. 1995; 35-36.
18. Stratton MR, Collins N, Lakhani SR, Sloane JP. Loss of heterozygosity in ductal carcinoma in situ of the breast. J. Pathol. 1995; 175; 195-201.
19. Moriya T, Silverberg SG. Intraductal carcinoma (Ductal carcinoma in situ) of the breast. A comparison of pure noninvasive tumours with those including different proportions of infiltrating carcinoma. Cancer 1994; 74: 2972-2978.
20. Frykberg ER, Bland KI. Overview of the biology and management of ductal carcinoma in situ of the breast. Cancer 1994; 74; 350-361.
21. Lagios MD. Duct carcinoma in situ: pathology and treatment. Surg. Clin. N. Am. 1990; 70; 853-871.
22. Schnitt SJ, Silen W, Sadowsky NL et al. Ductal carcinoma in situ (intraductal carcinoma) of the breast. N. Engl. J. Med. 1988; 318; 898-903.
23. Page DL, Lagios MD. Pathology and clinical evolution of ductal carcinoma in situ (DCIS) of the breast. Cancer Lett. 1994; 86; 1-4.
24. Eusebi V, Feudale E, Foschini MP et al. Long term follow up of In situ carcinoma of the breast. Semin. Diag. Pathol. 1994; 11; 223-235.
25. Page DL, Dupont WD, Rogers LW, Jensen RA, Schuyler PA. Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy. Cancer 1995; 76; 1197-1200.
26. Morrow M. The natural history of ductal carcinoma in situ-implications for clinical decision making. Cancer 1995; 49; 1113-1115
27. Lampejo OT, Barnes DM, Smith P, Millis RR. Evaluation of Infiltrating ductal carcinomas with a DCIS component: Correlation of the histologic type of the in situ component with grade of the infiltrating component. Semin. Diag. Pathol. 1994; 11; 215-222.
28. Robbins P, Pinder S, de Klerk N et al. Histological grading of breast carcinomas: A study of interobserver agreement. Human Pathol 1995; 26; 873-879.
29. Davis BW, Gelber RD, Goldhirsch A et al. Prognostic significance of tumor grade in clinical trials of adjuvant therapy for breast cancer with axillary lymph node metastasis. Cancer 1986; 58; 2662-2670.
30. Theissig F, Kunze KD, Haroske G, Meyer W. Histological grading of breast cancer: Interobserver reproducibility and prognostic significance. Pathol. Res. Pract. 1990; 186: 732-736.
31. Harvey JM, de Klerk N, Sterrett GF. Histological grading in breast cancer; Interobserver agreement and relation to other prognostic factors including ploidy. Pathology 1992; 24; 63-68.
32. Stenkvist B, Westman-Naeser S, Vegelius J et al. Analysis of reproducibility of subjective grading system for breast carcinoma. J. Clin. Pathol. 1979; 32: 979-985.
33. Hopton DS, Thorogood J, Clayden AD, Mackinnon D. Observer variation in histologic grading of breast cancer. Eur. J. Surg. Oncol. 1989; 15; 21-23.
34. Quinn CM. Histological classification of ductal carcinoma in situ. (letter). Eur. J. Cancer 1993; 29A: 1919-1920.
35. Page DL, Anderson TJ, Rogers LW. Carcinoma in situ (CIS). In Page DL, Anderson TJ eds. Diagnostic Histopathology of the Breast. London: Churchill Livingstone, 1987; 157-192.